Skip to main content
Premium Trial:

Request an Annual Quote

NINDS Eyes Next-Gen Sequencing Needs

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of Neurological Disorders and Stroke is considering how next-generation genome sequencing (NGS) will be applied in studies of neurological disorders, and is asking researchers in this area for information about how they plan to use the latest sequencing tools and genomic data in their work.

To find out how researchers aim to use next-gen whole genome sequencing (WGS), and what the needs are for sequencing, data storage, analysis, and annotation services, NINDS has released a new request for information seeking feedback from the extramural research community.

NINDS will use this feedback to inform and complement its efforts to assess the current and future whole genome sequencing needs of researchers studying a wide range of neurologic disease, and conducting basic research into the nervous system, the genetics of the brain, cognition, brain plasticity, neural signaling, learning, memory, motor control, and other areas.

"Since the technologic advancements in NGS have been rapid, the volume and complexity of the information captured through NGS challenges the storage and processing capabilities of many laboratories and institutions," NINDS said in the RFI.

To find out more about how those challenges should be met, NINDS wants researchers in the extramural community to describe what whole genome sequencing services are available at their institutions and which ones are planned, to describe the makeup of their research cohorts that will use whole genome sequencing, and to discuss how they expect WGS to contribute to their research areas.

The institute also wants to find out why researchers are seeking to use WGS instead of whole exome sequencing, what their sample requirements are expected to be, what kind of storage capacity they have at hand, how many samples they expect to sequence in the coming year, and what plans their labs have for handling and storing whole genome sequencing data.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.